Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma
Recruiting · NCT05919238 · Registry updated 2026-10-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Padeliporfin VTP Treatment for Unresectable Pancreatic Adenocarcinoma | Locally Advanced Unresectable Pancreatic Adenocarcinoma | Recruiting | Phase 1 | 2026-10-08 | NCT05919238 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Impact Biotech Ltd | 2 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| City of Hope | Duarte | United States | 238 |
| Shiba Medical Center | Ramat Gan | Israel | 1 |
| University of California Irvine | Irvine | United States | 30 |